Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 3 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 3 days agoWhy does Sanofi want the Novavax COVID vaccine? The Novavax COVID-19 vaccine, which is called...
Dow Jones Today: Dow Extends Winning Streak to Eight Days as Major Indexes Gain For Third...
Investopedia· 7 days agoMettler Toledo (MTD) led gains among S&P 500 stocks Friday, soaring 17% following a strong quarterly...
3 Hot Stocks to Buy That Still Look Undervalued
Morningstar· 4 days agoHere at Morningstar, we talk a lot about the dangers of chasing performance, or buying a stock, ETF, or fund because it’s on a hot streak. Morningstar...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 4 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via AOL· 2 days agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick...
Benzinga· 7 days agoEditor’s note: This story has been updated to correct an error in the price action of Charter...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 7 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 3 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...